Donoghue Forlines’s Medtronic MDT Stock Holding History

Donoghue Forlines’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.75M	Sell	20,303 -1,262	-6%	-$111K	0.44%	75
2026 Q2	$1.69M	Buy	21,565 +2,857	+15%	+$230K	0.44%	89
2026 Q1	$1.62M	Buy	18,708 +3,954	+27%	+$379K	0.45%	90
2025 Q4	$1.42M	Sell	14,754 -1,357	-8%	-$132K	0.44%	99
2025 Q3	$1.53M	Sell	16,111 -620	-4%	-$57K	0.47%	73
2025 Q2	$1.46M	Buy	16,731 +826	+5%	+$70K	0.42%	83
2025 Q1	$1.43M	Sell	15,905 -2,923	-16%	-$262K	0.45%	95
2024 Q4	$1.5M	Buy	+18,828	New	+$1.63M	0.5%	72
2019 Q4	–	Sell	-22,115	Closed	-$2.4M	–	184
2019 Q3	$2.4M	Buy	+22,115	New	+$2.31M	0.34%	98

Other funds holding MDT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

Beutel, Goodman & Co Toronto, Ontario, Canada $12.7B AUM 12.76% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Donoghue Forlines's MDT Position: Q3 2026 in Review

Donoghue Forlines reduced its Medtronic (MDT) stake by 5.9% in Q3 2026, selling an estimated $111K and leaving 20,303 shares worth $1.75M. The position accounts for 0.44% of the portfolio, ranked #75.

Donoghue Forlines first reported a position in MDT in Q3 2019 and has held it in 9 quarters since. The position peaked at $2.4M in Q3 2019. 1,271 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

Donoghue Forlines held 20,303 shares of Medtronic worth $1.75M as of Q3 2026.
Donoghue Forlines sold 1,262 Medtronic shares in Q3 2026, an estimated $111K.
Medtronic made up 0.44% of Donoghue Forlines's portfolio in Q3 2026, its #75 holding.
Donoghue Forlines first reported a position in Medtronic in Q3 2019 and has held it in 9 quarters since.
Donoghue Forlines's Medtronic position peaked at $2.4M in Q3 2019.
1,271 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Donoghue Forlines's 13F filing for Q3 2026, filed 2 Nov 2026.